Physiologically based pharmacokinetic modeling of tapentadol in children to support pediatric dose selection

Zilong Wang1, Yujie Yang2, Zhihai Cao1

  • 1School of Pharmacy, Anhui Medical University, Hefei 230601, China; Department of Clinical Pharmacology, The Second Affiliated Hospital of Anhui Medical University, Hefei 230601, China.

Insights

This study developed a physiologically based pharmacokinetic (PBPK) model to establish safe and effective tapentadol dosing regimens for pediatric patients across all age groups. The model ensures accurate tapentadol dosage recommendations for children.

Area of Science:

  • Pharmacokinetics and Pharmacodynamics
  • Pediatric Pharmacology
  • Computational Modeling

Background:

  • Tapentadol is an effective opioid analgesic for moderate to severe pain unresponsive to non-opioid analgesics.
  • Optimizing pediatric dosing is crucial due to physiological differences affecting drug disposition.
  • Physiologically based pharmacokinetic (PBPK) modeling offers a robust approach for pediatric drug dosage refinement.

Purpose of the Study:

  • To develop and validate a PBPK model for tapentadol disposition in pediatric populations.
  • To characterize tapentadol pharmacokinetics (PK) across diverse pediatric age groups.
  • To establish refined, age-specific dosing strategies for tapentadol oral solution in children.

Main Methods:

  • An adult PBPK model was adapted for pediatric use by scaling anatomical and physiological parameters.
  • Model validation involved comparing simulated plasma concentrations against empirical data.
  • Dosages were translated from adult to pediatric populations, with weight-adjusted doses assessed for different age strata.

Main Results:

  • The PBPK model accurately predicted tapentadol PK parameters in pediatric populations, with a mean absolute prediction error (MAPE) below 0.45.
  • Predicted to observed PK parameter ratios for adults ranged from 0.80 to 1.40.
  • A validated fixed-dose regimen for tapentadol oral solution was established for children from 0 to 18 years.

Conclusions:

  • The developed PBPK model successfully characterized tapentadol disposition in pediatric patients.
  • The study provides evidence-based, fixed-dose recommendations for tapentadol oral solution across pediatric age groups.
  • Findings support the utility of PBPK modeling for optimizing pediatric drug dosing, especially for drugs with complex metabolic pathways.

Related Concept Videos

Pharmacokinetic Models: Comparison and Selection Criterion01:26

Pharmacokinetic Models: Comparison and Selection Criterion

Physiological and compartmental models are valuable tools used in studying biological systems. These models rely on differential equations to maintain mass balance within the system, ensuring an accurate representation of the dynamic processes at play.
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
35
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models01:06

Model Approaches for Pharmacokinetic Data: Distributed Parameter Models

Pharmacokinetic models are mathematical constructs that represent and predict the time course of drug concentrations in the body, providing meaningful pharmacokinetic parameters. These models are categorized into compartment, physiological, and distributed parameter models.
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
54
Pharmacokinetic Models: Overview01:20

Pharmacokinetic Models: Overview

Pharmacokinetic models utilize mathematical analysis to achieve a detailed quantitative understanding of a drug's life cycle within the body. They are instrumental in simulating a drug's pharmacokinetic parameters, predicting drug concentrations over time, optimizing dosage regimens, linking concentrations with pharmacologic activity, and estimating potential toxicity.
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal...
538
Model Approaches for Pharmacokinetic Data: Compartment Models01:14

Model Approaches for Pharmacokinetic Data: Compartment Models

Compartmental analysis is a widely adopted approach to characterizing drug pharmacokinetics. It uses compartment models that conceptualize the body as a collection of reversibly communicating compartments, each representing a group of tissues exhibiting similar drug distribution characteristics. The movement rate of the drug between these compartments is typically described by first-order kinetics.
Two primary types of compartment models are recognized: mammillary and catenary. The more...
68
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches01:14

Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches

Drug disposition in the body is a complex process and can be studied using two major approaches: the model and the model-independent approaches.
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
77
Mechanistic Models: Overview of Compartment Models01:21

Mechanistic Models: Overview of Compartment Models

Mechanistic models, a category encompassing both physiological and compartmental modeling, differ from empirical models' approaches to incorporating known factors about the systems being modeled. Empirical models describe data with minimal assumptions, while mechanistic models aim to provide a robust description of available data by specifying assumptions and integrating known factors about the system. Compartmental analysis is a key example of a mechanistic model in pharmacokinetics and...
55